Mark Sullivan
- Urology top 2%
- Urinary Bladder and Prostate Research 7
-
- Renal cell carcinoma treatment 20
-
- Hormonal and reproductive studies 8
- Internal Medicine top 5%
-
- Renal and related cancers 14
-
- Nitric Oxide and Endothelin Effects 10
-
- Bladder and Urothelial Cancer Treatments 10
-
- Blood Coagulation and Thrombosis Mechanisms 8
-
- Atherosclerosis and Cardiovascular Diseases 8
- Co-authors
- Ronald VergonaBaby Martin-McNultyYi-Xin WangDennis W. WilsonJohn C. RutledgeValdeci da CunhaDoris M. ThamWilliam P. Dole
- Journals
- British Journal of Urology (14 papers)Atherosclerosis (4 papers)Thrombosis Research (4 papers)
- Partner nations
- United KingdomUnited StatesTaiwan
In The Last Decade
Mark Sullivan
112 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 135
- Cardiology and Cardiovascular Medicine 784
- Urology 214
- Pulmonary and Respiratory Medicine 923
- Endocrinology, Diabetes and Metabolism 407
- Internal Medicine 77
Countries citing papers authored by Mark Sullivan
This map shows the geographic impact of Mark Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sullivan more than expected).
Fields of papers citing papers by Mark Sullivan
This network shows the impact of papers produced by Mark Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sullivan. The network helps show where Mark Sullivan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2018 | 46 | |
| 3 | 2017 | 7 | |
| 4 | 2016 | 22 | |
| 5 | 2016 | 30 | |
| 6 | 2013 | 57 | |
| 7 | 2012 | 59 | |
| 8 | 2010 | 25 | |
| 9 | 2010 | 35 | |
| 10 | 2007 | 39 | |
| 11 | 2007 | 75 | |
| 12 | 2006 | 15 | |
| 13 | 2006 | 20 | |
| 14 | PPAR-α activation attenuates angiotensin II-induced vascular inflammation, arterial LDL accumulation and endothelial layer permeability in mice | 2005 | 1 |
| 15 | 2002 | 70 | |
| 16 | 2001 | 6 | |
| 17 | 2000 | 20 | |
| 18 | 1999 | 67 | |
| 19 | 1999 | 6 | |
| 20 | 1989 | 3 |
About Mark Sullivan
Mark Sullivan is a scholar working on Urology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 112 papers that have together received 3.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers), Nitric Oxide and Endothelin Effects (10 papers), Bladder and Urothelial Cancer Treatments (10 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Atherosclerosis and Cardiovascular Diseases (8 papers), Hormonal and reproductive studies (8 papers) and Urinary Bladder and Prostate Research (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (784 citations), Urology (214 citations) and Pulmonary and Respiratory Medicine (923 citations). Mark Sullivan has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include Ronald Vergona, Baby Martin-McNulty, Yi-Xin Wang, Dennis W. Wilson, John C. Rutledge, Valdeci da Cunha, Doris M. Tham, William P. Dole, Meredith Halks‐Miller and Jon Vincelette. Their work appears in journals such as British Journal of Urology, Atherosclerosis, Thrombosis Research, Urology and American Journal of Physiology-Heart and Circulatory Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.